The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002–2015
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Center (NCC-1710141, NCC-1610410)
This publication has 26 references indexed in Scilit:
- Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009PLOS ONE, 2013
- The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008Sexually Transmitted Diseases, 2013
- Economic Burden of Human Papillomavirus-Related Diseases in ItalyPLOS ONE, 2012
- Global Burden of Human Papillomavirus and Related DiseasesVaccine, 2012
- Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory PapillomatosisVaccine, 2012
- Economic burden of HPV-related cancers in FranceVaccine, 2011
- Attitudes, Intentions, and Perceived Barriers to Human Papillomavirus Vaccination Among Korean High School Girls and Their MothersCancer Nursing, 2011
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) VaccineThe Journal of Infectious Diseases, 2009
- Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional studyBMC Infectious Diseases, 2008